Biological Dynamics has appointed Paul Billings to its board of directors. Billings' addition increases board membership to four directors.
Billings currently serves as an executive-in-residence at Janssen Diagnostics, a division of Johnson & Johnson, and is the medical director of the IMPACT Cancer Care Program at Thermo Fisher Scientific. Previously, he has served on the scientific advisory board of the US Food and Drug Administration and the Genomic Medicine advisory committee at the Department of Veterans Affairs. Billings has also held academic appointments at Harvard University, the University of California San Francisco, Stanford University, and UC Berkeley; has served as a physician at a number of leading medical centers; and served as chief medical officer of Life Technologies and the genetic sciences division of Thermo Fisher Scientific.